Skip to content

David Potter

2 papers in the library · publishing 2008-2016

Papers

Sort Most recent Most cited

Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology March 1, 2016 Elena H Chartoff, Shayla R Ebner, Angela Sparrow et al.

Negative affective states can increase the rewarding value of drugs of abuse and promote drug taking. Chronic cocaine exposure increases levels of the neuropeptide dynorphin, an endogenous ligand at kappa opioid receptors (KOR) that suppresses dopamine release in the nucleus accumbens (NAc) and elicits negative affective states upon drug withdrawal. However, there is evidence that the effects...

Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology October 2008 Elena H Chartoff, David Potter, Diane Damez-Werno et al.

Stress and chronic exposure to drugs of abuse can trigger addictive and depressive disorders. Both stimuli increase activity of dynorphin, a neuropeptide that acts at kappa-opioid receptors (KORs). In humans, KOR agonists cause dysphoria, raising the possibility that dynorphin modulates the depressive-like effects of stress and chronic drug use. We examined if KOR activation alters sensitivity...